4 key notes on complications, readmission for spine surgery patients who have blood transfusions

Written by Laura Dyrda | April 20, 2017 | Print  |

A new study published in Spine examines the complication rates, readmissions and patient reported outcomes for spine surgery patients with blood transfusions.

The study authors examined 160 elective spine surgery patients at a major academic medical center and assessed comorbidities as well as complication rates. There wasn't a significant difference in baseline characteristics. The researchers found:


1. The patients who received blood transfusions reported 44.67 percent complication rate, compared with 23 percent complication rate among nontransfusion patients.


2. In total, 9.38 percent of the patients had 30-day readmissions; in the transfusion cohort, 16.67 percent of patients were readmitted in the first 30 days after discharge, compared with 5 percent in the nontransfusion cohort.


3. Intra- or perioperative allogeneic RBC transfusion was an independent predictor of readmissions within 30 days of surgery.


4. The study authors concluded, "Our study suggests that allogeneic RBC transfusions may be associated with increased postoperative complications, length of stay and 30-day readmission rates."


More articles on spine surgery:
9 methods to improve spine practice management
17 spine devices receive FDA 510(k) clearance in March 2017
Spine databases: Is the NIS or NSQIP better? 5 things to know

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months